[1]
M. S. and K. Kumar M., “Expert opinion on the prescription practice of silodosin for treating benign prostatic hyperplasia patients in Indian clinical settings”, Int J Adv Med, vol. 11, no. 2, pp. 94–98, Feb. 2024.